Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-30 of 63
1-30 of 63
Filter
Noubar Afeyan
Founder & CEO at Flagship Pioneering
antibody, antigen, antiviral drug, clinical endpoint, clinical trial, covid-19 vaccine, drug development, epitope, experiment, imitation, immune system, infection, inflammatory bowel disease, medication, mind, moderna covid-19 vaccine, pharmaceutical formulation, placebo, research and development, severe acute respiratory syndrome coronavirus 2, sustainability, t-cell receptor, vaccine, virus
Najat Khan
Chief Data Science Officer at Janssen R&D
antibody, antigen, antiviral drug, clinical endpoint, clinical trial, covid-19 vaccine, drug development, epitope, experiment, imitation, immune system, infection, inflammatory bowel disease, medication, mind, moderna covid-19 vaccine, pharmaceutical formulation, placebo, research and development, severe acute respiratory syndrome coronavirus 2, sustainability, t-cell receptor, vaccine, virus
Anne Fischer
Program Manager at DARPA
antibody, antigen, antiviral drug, clinical endpoint, clinical trial, covid-19 vaccine, drug development, epitope, experiment, imitation, immune system, infection, inflammatory bowel disease, medication, mind, moderna covid-19 vaccine, pharmaceutical formulation, placebo, research and development, severe acute respiratory syndrome coronavirus 2, sustainability, t-cell receptor, vaccine, virus
Phil Sharp
Professor at MIT
antibody, antigen, antiviral drug, clinical endpoint, clinical trial, covid-19 vaccine, drug development, epitope, experiment, imitation, immune system, infection, inflammatory bowel disease, medication, mind, moderna covid-19 vaccine, pharmaceutical formulation, placebo, research and development, severe acute respiratory syndrome coronavirus 2, sustainability, t-cell receptor, vaccine, virus
Donald McCaffrey
CEO at Resverlogix Corp.
alzheimer's disease, breakthrough therapy, chronic illness, dementia, diabetes, diabetes medication, drug development, epigenetics, fatty liver disease, food and drug administration, hazard, heredity, human genome, hypertension, kidney disease, medication, non-alcoholic fatty liver disease, pharmaceutical industry, placebo, relative risk, risk management, rna, royalty payment, sglt2 inhibitor, standard of care, synergy
Jing Gao
Associate Professor at University at Buffalo, USA
acm 2020, artificial intelligence, big data, causal inference, causality, computer science 2020, computer science event 2020, computer vision, correlation and dependence, counterfactual conditional, covariance, data science, deep learning 2020, dependent and independent variables, experiment, hypothesis, kdd2020, knowledge, linear regression, logistic regression, machine learning, machine learning 2020, pearson correlation coefficient, placebo, prediction, recommender system, regression analysis, risk, sample size determination, science, statistical classification, statistical inference, truth
Zhixuan Chu
PhD student at University of Georgia, USA
acm 2020, artificial intelligence, big data, causal inference, causality, computer science 2020, computer science event 2020, computer vision, correlation and dependence, counterfactual conditional, covariance, data science, deep learning 2020, dependent and independent variables, experiment, hypothesis, kdd2020, knowledge, linear regression, logistic regression, machine learning, machine learning 2020, pearson correlation coefficient, placebo, prediction, recommender system, regression analysis, risk, sample size determination, science, statistical classification, statistical inference, truth
Liuyi Yao
PhD student at University at Buffalo, USA
acm 2020, artificial intelligence, big data, causal inference, causality, computer science 2020, computer science event 2020, computer vision, correlation and dependence, counterfactual conditional, covariance, data science, deep learning 2020, dependent and independent variables, experiment, hypothesis, kdd2020, knowledge, linear regression, logistic regression, machine learning, machine learning 2020, pearson correlation coefficient, placebo, prediction, recommender system, regression analysis, risk, sample size determination, science, statistical classification, statistical inference, truth
Sheng Li
Assistant Professor at Computer Science at University of Georgia
acm 2020, artificial intelligence, big data, causal inference, causality, computer science 2020, computer science event 2020, computer vision, correlation and dependence, counterfactual conditional, covariance, data science, deep learning 2020, dependent and independent variables, experiment, hypothesis, kdd2020, knowledge, linear regression, logistic regression, machine learning, machine learning 2020, pearson correlation coefficient, placebo, prediction, recommender system, regression analysis, risk, sample size determination, science, statistical classification, statistical inference, truth
Zheyan Shen
PhD Candidate at Tsinghua University
acm 2020, artificial intelligence, big data, causal inference, causality, computer science 2020, computer science event 2020, computer vision, correlation and dependence, counterfactual conditional, covariance, data science, deep learning 2020, dependent and independent variables, experiment, hypothesis, kdd2020, knowledge, linear regression, logistic regression, machine learning, machine learning 2020, pearson correlation coefficient, placebo, prediction, recommender system, regression analysis, risk, sample size determination, science, statistical classification, statistical inference, truth
Peng Cui
Associate Professor at Tsinghua University
acm 2020, artificial intelligence, big data, causal inference, causality, computer science 2020, computer science event 2020, computer vision, correlation and dependence, counterfactual conditional, covariance, data science, deep learning 2020, dependent and independent variables, experiment, hypothesis, kdd2020, knowledge, linear regression, logistic regression, machine learning, machine learning 2020, pearson correlation coefficient, placebo, prediction, recommender system, regression analysis, risk, sample size determination, science, statistical classification, statistical inference, truth
Jing Pan
Data Scientist at Uber
accuracy and precision, analytics, apple inc., brand, causality, experiment, machine learning, marketing mix, mobile app, modeling, motivation, neural network, placebo, prediction, predictive modelling, profit (economics), profit maximization, python, recommender system, reddit, sales, sensitivity analysis, social media, use case, waze, wisdom
Anshik Anshik
Data Science Associate Consultant at ZS
biomarker, biopsy, blood sugar level, clinical trial, decision-making, design intelligence, diabetes, dose (biochemistry), food and drug administration, institutional review board, liver biopsy, machine learning, major depressive disorder, medication, nothing, ontology, parsing, pharmaceutical industry, phases of clinical research, placebo, preclinical development, research, signs and symptoms, simulation, touchpoint, xml
Mauro F Cardoso Lins
Medical Director at Clinica Escola Do Autista translates as School Clinic for Autism
adherence (medicine), ageing, antipsychotic, anxiety, attention deficit hyperactivity disorder, autism, autism spectrum, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical psychology, diarrhea, disease, dog, electroencephalography, emergency department, endocannabinoid system, epilepsy, epileptic seizure, fish oil, food and drug administration, hash oil, health care, health claim, hemp, medical cannabis, medication, medicine, mental disorder, miracle, mitochondrion, neurology, pain, pharmaceutical industry, pharmacist, physician, placebo, psychotherapy, regulatory compliance, science, spectrum disorder, tetrahydrocannabinol
Sandra Carrillo
Professor at Medical Cannabis Research & Education
agriculture, anticonvulsant, benzodiazepine, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, chemotherapy, clinical trial, computer security, dose (biochemistry), drug, endocannabinoid system, evidence-based medicine, fibromyalgia, food and drug administration, forecasting, headache, medical cannabis, medication, opiate, opioid, pain, pain management, peripheral neuropathy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, psychiatrist, psychology, psychotherapy, public company, question, science, spasticity, substance abuse, synapse, technology, tetrahydrocannabinol, water
Kriss Harris
Contract Computational Statistician at Eli Lilly and Company
adoption, annotate graphs, biostatistician, cartesian coordinate system, clinical trial, color, color graphs, data scientist, dose (biochemistry), email, emotion, experience, forest plot, graph of a function, hazard ratio, health care, kaplan-meoer, license, life sciences, linkedin, macro (computer science), median, microsoft excel, pain, placebo, programmer, programming, risk, sas, sas global forum, sas global forum 2021, sas specialists limited, sas technology, scatter plot, sg graph, statistician, statistics, super static sg graphs, swimmer plot, treatment and control groups, truth, truth table, variable (computer science), virtual sas global forum, virtual sas global forum 2021
Baldur Magnusson
Senior Director Biostatistics at Novartis
annotation, attention, consciousness, covid-19 pandemic, data science, data visualization , experiment, goal, habit, information, medication, mind, placebo, pointer (computer programming), question, reality, reason, sense, shame, silence, statistical inference, statistics, visual communication, visualization (graphics), where's wally?
Kristen Habacht
Global Head of EDR Sales at Atlassian
analytics, business-to-business, clinical trial, cold calling, contract, cost, customer, experiment, freemium, goal, insurance, metaphor, negotiation, placebo, price, pricing, sales, sales process engineering, salesforce, self-service, software , space, truth, twitter
Jorge A. Escudero
Pharmacist at CBD Apothecary
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Richard Harris
Founder at Great Health and Wellness
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anti-inflammatory, anticoagulant, antipsychotic, appetite, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, bronchodilator, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis industry, cannabis sativa, cannabis strain, cerebellum, certificate of analysis, chemical synapse, chronic condition, chronic fatigue syndrome, depression (mood), diabetes, dispensary, dopamine, dose (biochemistry), dravet syndrome, drug, drug enforcement administration, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, family medicine, fibromyalgia, food and drug administration, free market, gateway drug effect, good manufacturing practice, gpr55, hair loss, heartburn, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medication, medicine, mental disorder, mental health, methotrexate, morphine, national health service, nervous system, norepinephrine, nursing, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, personalized medicine, pharmaceutical industry, pharmacology, pharmacy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, pulmonary fibrosis, randomized controlled trial, residency (medicine), rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, self-medication, serotonin, spasticities, sports medicine, sympathetic nervous system, symptom, synapse, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vagus nerve, vagus nerve stimulation, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Kevin Carrillo
Chief Operating Officer at Cannabinoid Nation
advertising, arthritis, audience measurement, blog, brand, brand awareness, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis edible, chocolate, coca-cola, contract, dietary supplement, digital marketing, effects of cannabis, emergency department, endocannabinoid system, facebook, fibromyalgia, food, food science, game balance, google, google search, gpr55, hashtag, homeostasis, hot chocolate, hydroxychloroquine, instagram, internet, linkedin, liquid, medical school, medicine, minimum viable product, money, morphine, news, newspaper, opiate, pay to play, pepsi, placebo, product sample, psilocybin mushroom, randomized controlled trial, research, search engine optimization, shelf life, small business, social media, social media marketing, sports medicine, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, twitter, vaporizer (inhalation device), whole foods market, yeast, youtube
Jim Sabogal
Senior Director for Healthcare and Life Sciences at T-Systems North America
5g, algorithm, authentication, basement, biology, biometrics, blockchain, canal, cargo, clinical trial, cloud computing, cold chain, computer hardware, computer network, coronavirus disease 2019, dose (biochemistry), electroencephalography, emergency department, fingerprint, food and drug administration, global positioning system, health, health care, health care in the united states, health informatics, internet of things, interoperability, inventory, logistics, lubricant, machine learning, medical record, medical ventilator, medication, nursing, operation warp speed, panama canal, patient, pharmacy, placebo, port, prescription drug, privacy, public health surveillance, reason, recycling, refrigerator, remote patient monitoring, science, scotty (star trek), shame, supply chain, surgery, surveillance, technology, telehealth, text messaging, the internet of things, time, transport, ventilation (architecture), wearable technology, wi-fi
Joseph Nowell
Owner/Compounding Pharmacist at The Fresh Pharmacy
big data, brand, cannabidiol, cannabinoid, cannabis (drug), cannabis sativa, craft brewery and microbrewery, customer, dose (biochemistry), food, goal, herb, medication, mirror, molecule, placebo, scientific method, stress (biology), taste, thalidomide, water, whole foods market, wine, wood
Christina Sasser
CEO at Vital Leaf
adele, agriculture, android (operating system), ann arbor, michigan, attention, ayurveda, bank of america, big data, brand, california, canada, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis sativa, china, chinese herbology, craft brewery and microbrewery, customer, debate, dose (biochemistry), drug, dvd, flower, food, food and drug administration, goal, grocery store, heat, heavy metal music, hemp, herb, ice cream, illinois, medication, michael jackson, microphone, mirror, molecule, muhammad ali, nanotechnology, new york city, news, nutraceutical, ohio, percentage, pesticide, pharmaceutical industry, placebo, psalms, reggae, retail, runway, scientific method, seed, snow removal, spotify, stress (biology), taste, thalidomide, traditional chinese medicine, united states, united states department of agriculture, water, whole foods market, wine, wood
Brian Beckley
Managing Editor at Marijuana Venture
big data, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabinoid, cannabis (drug), cannabis sativa, chromatography, clinical trial, craft brewery and microbrewery, crisis management, customer, dietary supplement, dose (biochemistry), end-user, food, fraud, goal, herb, high-performance liquid chromatography, laboratory, marketplace, medication, mining, mirror, molecule, national institutes of health, placebo, reason, research, right to know, scientific method, stress (biology), taste, thalidomide, the end-user, thin-layer chromatography, warranty, water, whole foods market, wine, wood
Kayla Fioravanti
Business Owner at Ology Essentials
aromatherapy, bank, big data, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis sativa, clinical trial, craft brewery and microbrewery, crop insurance, curriculum, customer, dose (biochemistry), evidence-based medicine, finance, food, food and drug administration, goal, herb, medical cannabis, medical prescription, medication, mirror, molecule, organized crime, pain management, payment, pharmaceutical industry, placebo, placebo-controlled study, prescription drug, scientific method, stress (biology), taste, tetrahydrocannabinol, thalidomide, water, whole foods market, wine, wood
1 2 3
1-30 of 63